| Patent Number |
Title Of Patent |
Date Issued |
| 7049289 |
Labelled glutamine and lysine analogues |
May 23, 2006 |
| Synthetic analogues of lysine and glutamine are provided which function as substrates for the fibrin-stabilising enzyme Factor XIIIa even when labelled with a detectable moiety. The use of suitable protecting groups provides compounds which possess reduced susceptibility to in vivo m |
| 6897209 |
Labelled factor XIIIa substrates |
May 24, 2005 |
| A complex of a radiometal or paramagnetic metal ion with a metal chelating agent such as a diaminedioxime has attached thereto a substituent of formula (Y).sub.m -A-NHR).sub.k can function as a substrate for the fibrin-stabilizing Factor XIIIa. The complex is useful for the diagnosis |
| 6758840 |
Drug delivery device |
July 6, 2004 |
| The invention relates to drug delivery devices for insertion into the vagina, rectum or nasal cavity comprising a body, a layer of fluid-impermeable material on at least part of said body and one or more pharmaceutical agents disposed on the surface of the material remote from said b |
| 6653299 |
Labelled factor XIIIa substrates |
November 25, 2003 |
| A complex of a radiometal or paramagnetic metal ion with a metal chelating agent such as a diaminedioxime has attached thereto a substituent of formula --(Y).sub.m --A--NHR, can function as a substrate for the fibrin-stabilizing Factor XIIIa. The complex is useful for the diagnosis o |
| 6375926 |
Labelled elastase inhibitors |
April 23, 2002 |
| A human leucocyte elastase (HLE) inhibitor labelled with a detector moiety where the inhibitor is synthetic and has a molecular weight of less than 2000, is useful for the diagnostic imaging of sites of inflammation of infection in vivo, for labelling leucocytes in vitro, or for radiothe |
